Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Chronic Disease Management Market size was over USD 7.99 billion in 2024 and is expected to reach USD 46.56 billion by the end of 2037, growing at around 14.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of chronic disease management is assessed at USD 8.93 billion.
The reason behind the growth is impelled by the increasing use of tobacco across the globe which has led to an increase in the prevalence of various types of chronic diseases, which is increasing the death rate and the need for long-term intensive care.
For instance, the tobacco epidemic, which kills more than 6 million people a year worldwide, is known to be one of the greatest risks to public health the world has ever seen.
The worldwide upsurge in chronic obstructive pulmonary disease (COPD) across the world is believed to fuel the chronic disease management market. Chronic obstructive pulmonary disease (COPD) is a long-term disease that occurs when the lungs and air route become damaged. The upsurge in COPD is also leading to an increase in demand for chronic disease management. As per the data provided by the World Health Organization, globally, 3.23 million people died from chronic obstructive pulmonary disease (COPD) in 2019.
Chronic Disease Management Market: Growth Drivers and Challenges
Growth Drivers
- Increasing Geriatric Population with Decreased Immunity– Despite weak immune systems aging brings several other health issues that require intensive care and health monitoring of old people. So, an increase in the geriatric population is fueling the demand for chronic disease management. According to the data provided by the World Health Organization (WHO), the population of people aged 60 and up has increased from 1 billion in 2020 to 1.4 billion around the globe.
- Rise in Musculoskeletal Diseases - A collection of illnesses known together as musculoskeletal disorders affect the bones, tendons, muscles, cartilage, and other components of the musculoskeletal system. For instance, back discomfort, osteoarthritis, rheumatoid arthritis, and osteoporosis are among these disorders. Furthermore, if osteoarthritis treatment is not provided effectively, can lead to major health issues. In addition, musculoskeletal ailments are the main cause of disability worldwide. For instance, worldwide, 1.71 billion people have been suffering from musculoskeletal conditions.
Challenges
- High-Cost Associated with Chronic Diseases Treatment- Chronic diseases are long-term illnesses that need treatment for a lifetime in many cases, such as diabetes. The medications and therapy procedures for chronic diseases are very expensive such as chemotherapy in the case of cancer. HIV and AIDS also include in this category, hampering the growth of the market.
- High Initial Investments
- Lack of Trained Workforce with Cross-Functional Skills
Chronic Disease Management Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
14.6% |
|
Base Year Market Size (2024) |
USD 7.99 billion |
|
Forecast Year Market Size (2037) |
USD 46.56 billion |
|
Regional Scope |
|
Chronic Disease Management Segmentation
Disease Type (Cancer, Diabetes, Cardiovascular Diseases, Arthritis, Asthma, Chronic Obstructive Pulmonary Disorders (COPD), Stroke)
The cardiovascular diseases segment is estimated hold 30% share of the global chronic disease management market in the coming years owing to the growing prevalence of chronic illnesses in the world. Moreover, heart failure, coronary artery disease, stroke, and other illnesses that impact the blood vessels and the heart are all included in CVD. Blood pressure, high blood cholesterol, smoking, inactivity, a poor diet, and obesity are all CVD risk factors. A major amount of the global illness burden is attributable to CVD, which is one of the main causes of mortality worldwide.
According to the World Health Organization (WHO), the largest cause of mortality worldwide is cardiovascular disease (CVD), followed by cancer, respiratory conditions, and diabetes. Furthermore, more than 17 million people die every year owing to cardiovascular diseases around the world.
Type (Solutions, Services)
Chronic disease management market from the solutions segment is set to garner a notable share shortly on the back of increased awareness regarding the use of cloud-based healthcare solutions. The best option to enable patients to share health information for advancing the treatment of chronic diseases is determined to be a hybrid cloud solution as it enhances the environment for healthcare, enables remote monitoring, boosts operational effectiveness, and reduces costs. This can help in the management of chronic diseases more efficiently.
Our in-depth analysis of the global chronic disease management market includes the following segments:
|
Type |
|
|
Deployment Mode |
|
|
Disease Type |
|
|
Service Type |
|
|
End-User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportChronic Disease Management Industry- Regional Synopsis
North American Market Forecast
Chronic Disease Management market in North America is predicted to account for the largest share of 47% by 2037 impelled by increasing spending in healthcare. This has led to an increase in access to quality medical treatments for people with chronic diseases in the region. Besides this, owing to the availability of sufficient resources more specialized training is being given to the medical professionals in the region for managing chronic conditions. In 2021, the United States spent over 2% more on health care, amounting to roughly USD 4 trillion or around USD 12,910 per person.
European Market Statistics
The Europe chronic disease management market is estimated to hold the second largest of 29%, during the forecast timeframe led by growing awareness regarding health. As a result, more people in the region can access medical care for the timely management and diagnosis of several chronic conditions.
Companies Dominating the Chronic Disease Management Market
- WellSky Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Cedar Gate Technologies
- Pegasystems Inc.
- Koninklijke Philips N.V
- Altruista Health
- Cognizant TriZetto Software Group Inc
- Infosys Limited
- Hinduja Global Solutions Ltd.
- Epic Systems Corporation
- NXGN Management
In the News
- WellSky Corporation launched new predictive analytics capabilities that will make it easier for hospitals, payers, and post-acute care providers to recognize patients who need hospice care and will enable more than 10 million hospital discharges annually.
- Biofourmis Inc. introduced a chronic condition-management service dubbed Biofourmis Care that focuses on managing lipids, atrial fibrillation, diabetes, hypertension, and heart failure, and will further enable it to provide care for every stage of the care continuum, and remote monitoring for patients after discharge.
Author Credits: Radhika Pawar
- Report ID: 4242
- Published Date: Oct 10, 2024
- Report Format: PDF, PPT
